Trans dermal estrogen (oestrogel) for endometrial preparation in freeze embryo transfer cycle: An RCT

BACKGROUND

Estrogen and progesterone are two crucial factors for endometrial preparation in frozen embryo transfer (FET) cycles. Studies assessing different forms of estradiol in FET have published already but literature lacks enough surveys on transdermal estrogen application in reproductive medicine.

OBJECTIVE

To investigate the effects of trans dermal estrogen (Oestrogel) on pregnancy rates in patients that candidate for FET cycle.

MATERIALS AND METHODS

In this randomized clinical trial, 100 women undergoing FET cycles referred to Imam Khomeeini Hospital were enrolled in two groups, randomly. Group I received 8 mg/day estradiol valerate (E2 tablet) orally and group II were treated with 6 mg/day transdermal oestrogel gel after suppression with gonadotropin releasing hormone agonist. In both groups medication were started in the first day of menstruation cycle and continued until endometrial thickness reached 8 mm. Pregnancy rates (chemical, clinical, and ongoing), abortion rate, live birth rate, and frequency of complications were compared between two groups.

RESULTS

Chemical and clinical pregnancy rates were not significantly different between two groups (p=0.384). The abortion rate was significantly lower in group II than group I (p=0.035). Ongoing pregnancy and the live birth rates were significantly higher in group II (p=0.035). The rate of complication was not different in two groups.

CONCLUSION

Oestrogel seems to enhance ongoing pregnancy and live birth rates in comparison to estradiol valerate tablet.

Perinatal outcome after diagnosis of oligohydramnious at term

Background:

Oligohydramnious is threatening condition to fetal health for which some treatment are available and some are under evaluation. Oligohydramnious, is associated with increased pregnancy complication, congenital anomalies and perinatal mortality. There is an inverse relationship between the amniotic fluid index (AFI) and the adverse perinatal outcome. Oligo hydramnlious is clinical condition characteries by amniotic fluid index (AFI) of 5cm or less. Its incidence is 3-5 % of all the pregnancies an accurate and reproducible method of determining abnormality in amniotic fluid volume (AFI) is sonographic asessment of amniotic fluid index (AFI). It often increase the risk of small for gestational age (SGA) and also the incidence of cesarean section, meconium stained, low apgar score and Neonatal intensive care (NICU) admission.

Objectives:

The aim of study was to analyze the fetal out come in low risk pregnant women with oligohydramnious at term. This is a prospective, descriptive study.

Materials and Methods:

The study was conducted at Amiralmomenin hospital in Zabol for a period of 8 months from 2012/Mar/27 to 2012/Nov/5.It included 100 pregnant women diagnosed with the AFI of or less than 5cm at term. Control group included 300 pregnant women with AFI more than 8cm. Comparison was done between the study group and the control group. Regarding the fetal and pregnancy outcome using chi square and p value, detail were recorded in terms of fetal weight, apgar score at 1 and 5 minutes.

Results:

Mode of delivery, NICU admission neonatal death and induction of labour. Oligohydramnious is associated with a high rate of pregnancy complication and increased preinatal morbidity and mortality. Women with oligohydramnious usually have low birth babies.

Conclusions:

However, it can expect a safe and good outcome for which proper fetal surveillance and regular antenatal care visits are required.